Briciclib structure
|
Common Name | Briciclib | ||
---|---|---|---|---|
CAS Number | 865783-99-9 | Molecular Weight | 474.419 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 762.6±70.0 °C at 760 mmHg | |
Molecular Formula | C19H23O10PS | Melting Point | N/A | |
MSDS | N/A | Flash Point | 415.0±35.7 °C |
Use of BriciclibBriciclib is a water soluble derivative of ON 013100, and has the potential in targeting eIF4E for solid cancers. |
Name | 2-Methoxy-5-({[(E)-2-(2,4,6-trimethoxyphenyl)vinyl]sulfonyl}methy l)phenyl dihydrogen phosphate |
---|---|
Synonym | More Synonyms |
Description | Briciclib is a water soluble derivative of ON 013100, and has the potential in targeting eIF4E for solid cancers. |
---|---|
Related Catalog | |
Target |
eIF4E[1] |
In Vitro | Briciclib has the potential in targeting eIF4E. Briciclib shows inhibitory activity against the proliferation of mantle cell leukemia (EKO-1 and MINO), breast (MCF7 and MDA-MB-231), gastric (AGS), and esophageal (OE19, OE33, and FLO-1) cancer cell lines with GI50s of 9.8-12.2 nM, and with no toxicity on normal endothelial cells. Briciclib dose-dependently reduces the expression of cyclin D1 and c-Myc in breast and MCL cancer cell lines within 8 hours[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 762.6±70.0 °C at 760 mmHg |
Molecular Formula | C19H23O10PS |
Molecular Weight | 474.419 |
Flash Point | 415.0±35.7 °C |
Exact Mass | 474.074951 |
PSA | 156.01000 |
LogP | 0.89 |
Appearance of Characters | white solid |
Vapour Pressure | 0.0±2.7 mmHg at 25°C |
Index of Refraction | 1.578 |
Storage condition | -20℃ |
2-Methoxy-5-({[(E)-2-(2,4,6-trimethoxyphenyl)vinyl]sulfonyl}methyl)phenyl dihydrogen phosphate |
ON 014185 |
Phenol, 2-methoxy-5-[[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]-, dihydrogen phosphate |
Briciclib |
Phenol, 2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]-, 1-(dihydrogen phosphate) |